Atherosclerotic Cardiovascular Disease Risk and Evidence-based Management of Cholesterol
- PMID: 24926443
- PMCID: PMC4049051
- DOI: 10.4103/1947-2714.132916
Atherosclerotic Cardiovascular Disease Risk and Evidence-based Management of Cholesterol
Abstract
An elevated level of low-density lipoprotein cholesterol is directly associated with development of atherosclerotic cardiovascular disease, which may present as coronary heart disease, stroke, and peripheral arterial disease. The new cholesterol management guidelines from the American College of Cardiology and the American Heart Association aim to address a comprehensive approach to prevent and reduce the risk of atherosclerotic cardiovascular disease. The new guidelines recommend initiation of heart healthy lifestyle modifications and 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitor ("statin") therapy in individuals who are at a high risk for atherosclerotic cardiovascular disease. It is estimated that these guidelines could result in "statin" therapy for one in every three adults in the United States. This article presents a review of the current cholesterol management guidelines, recommendations from relevant randomized controlled trials and meta-analyses obtained from the searches in Medline/PubMed and Cochrane Database of Systematic Reviews, and publications from the Centers for Disease Control and Prevention, the Centers for Medicare and Medicaid Service, and the United States Preventive Services Task Force.
Keywords: Atherosclerotic cardiovascular disease; cholesterol management; statin.
Conflict of interest statement
Figures
Similar articles
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.Endocr Pract. 2017 Apr;23(Suppl 2):1-87. doi: 10.4158/EP171764.APPGL. Endocr Pract. 2017. PMID: 28437620
-
Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.J Am Coll Cardiol. 2019 Jun 25;73(24):3210-3227. doi: 10.1016/j.jacc.2018.11.004. Epub 2018 Nov 10. J Am Coll Cardiol. 2019. PMID: 30423394
-
Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Circulation. 2019 Jun 18;139(25):e1144-e1161. doi: 10.1161/CIR.0000000000000626. Epub 2018 Nov 10. Circulation. 2019. PMID: 30586775
-
Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug. Report No.: 14-05204-EF-2. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug. Report No.: 14-05204-EF-2. PMID: 27559556 Free Books & Documents. Review.
-
New cholesterol guidelines for the management of atherosclerotic cardiovascular disease risk: a comparison of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines with the 2014 National Lipid Association recommendations for patient-centered management of dyslipidemia.Cardiol Clin. 2015 May;33(2):181-96. doi: 10.1016/j.ccl.2015.02.001. Cardiol Clin. 2015. PMID: 25939292 Review.
Cited by
-
Rosuvastatin Slows Progression of Carotid Intima-Media Thickness: The METEOR-China Randomized Controlled Study.Stroke. 2022 Oct;53(10):3004-3013. doi: 10.1161/STROKEAHA.120.031877. Epub 2022 Aug 26. Stroke. 2022. PMID: 36017704 Free PMC article. Clinical Trial.
-
Transferrin predicts trimethylamine-N-oxide levels and is a potential biomarker of cardiovascular disease.BMC Cardiovasc Disord. 2022 May 10;22(1):209. doi: 10.1186/s12872-022-02644-3. BMC Cardiovasc Disord. 2022. PMID: 35538408 Free PMC article.
-
Prevalence and associated factors of uncontrolled hyperlipidemia among Thai patients with diabetes and clinical atherosclerotic cardiovascular diseases: a cross-sectional study.BMC Res Notes. 2021 Mar 25;14(1):118. doi: 10.1186/s13104-021-05535-6. BMC Res Notes. 2021. PMID: 33766082 Free PMC article.
-
Diet and Nutraceutical Supplementation in Dyslipidemic Patients: First Results of an Italian Single Center Real-World Retrospective Analysis.Nutrients. 2020 Jul 10;12(7):2056. doi: 10.3390/nu12072056. Nutrients. 2020. PMID: 32664400 Free PMC article.
-
Development of Novel DNA-Encoded PCSK9 Monoclonal Antibodies as Lipid-Lowering Therapeutics.Mol Ther. 2019 Jan 2;27(1):188-199. doi: 10.1016/j.ymthe.2018.10.016. Epub 2018 Nov 15. Mol Ther. 2019. PMID: 30449662 Free PMC article.
References
-
- Atlanta, GA: Morbidity and Mortality Weekly Report; 2012. [Accessed March 20, 2014]. Prevalence of cholesterol screening and high blood cholesterol among adults - United States, 2005, 2007, and 2009. Centers for Disease Control and Prevention. at http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6135a2.htm . - PubMed
-
- Baltimore, MD: Chartbook; 2012. [Accessed March 20, 2014]. Chronic Conditions among Medicare Beneficiaries. Centers for Medicare and Medicaid Services. at http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trend... .
-
- Stone NJ, Robinson J, Lichtenstein AH, Bairey Merz CN, Lloyd-Jones DM, Blum CB, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology - American Heart Association Task Force on Practice Guidelines. Circulation. 2013 [In Press] - PubMed
-
- Atlanta, GA: Morbidity and Mortality Weekly Report; 2011. [Accessed March 20, 2014]. Vital signs: Prevalence, treatment, and control of high levels of low-density lipoprotein Cholesterol, United States, 1999 - 2002 and 2005 - 2008. Centers for Disease Control and Prevention. at http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6004a5.htm . - PubMed
-
- Rockville, MD: U.S. Preventive Services Task Force Recommendation Statement; 2008. [Accessed March 20, 2014]. Screening for Lipid Disorders in Adults. United States Preventive Services Task Force. at http://www.uspreventiveservicestaskforce.org/uspstf08/lipid/lipidrs.htm .
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
